Fred Hutchinson Cancer Center competitive analysis

Latest publications and patents of Fred Hutchinson Cancer Center New

Explore the latest publications and patents granted to Fred Hutchinson Cancer Center, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Fred Hutchinson Cancer Center

Apr 27, 2022High Efficiency Targeted In Situ Genome-Wide ProfilingGranted And Under Opposition
Jan 12, 2022Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)Revoked
Dec 30, 2020Compositions And Methods For Accurately Identifying MutationsGranted And Under Opposition
Nov 18, 2020Method And Compositions For Cellular ImmunotherapyGranted And Under Opposition
Nov 4, 2020Method And Compositions For Cellular ImmunotherapyGranted And Under Opposition
Jan 17, 2018Compositions And Methods For Accurately Identifying MutationsRevoked

Explore Fred Hutchinson Cancer Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 27, 2022High Efficiency Targeted In Situ Genome-Wide Profiling1
Jan 12, 2022Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
Dec 30, 2020Compositions And Methods For Accurately Identifying Mutations3
Nov 18, 2020Method And Compositions For Cellular Immunotherapy1
Nov 4, 2020Method And Compositions For Cellular Immunotherapy1
Jan 17, 2018Compositions And Methods For Accurately Identifying Mutations1

Latest PTAB cases involving Fred Hutchinson Cancer Center

Discover the latest PTAB cases involving Fred Hutchinson Cancer Center, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Fred Hutchinson Cancer Center

IPR2023-00760Mar 22, 2023MILTENYI BIOMEDICINEFRED HUTCHINSON CANCER CENTERInstitution Denied

Peer Comparison New

IP litigation analysis comparing Fred Hutchinson Cancer Center with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
FRED HUTCHINSON CANCER CENTER - 9 - 1Non-Active
JAMES POOLE151 - - - Highly Aggressive
KONIG SZYNKA TILMANN VON RENESSE34 - - - Highly Aggressive
STRAWMAN329 - - - Highly Aggressive